A human translation of research on the neurobehavioral reward and reinforcement of flavored electronic nicotine delivery systems (ENDS)
神经行为奖励和调味电子尼古丁输送系统 (ENDS) 强化研究的人类翻译
基本信息
- 批准号:10671683
- 负责人:
- 金额:$ 38.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcetatesAcuteAdultAgeAppleAutomobile DrivingBloodBlood - brain barrier anatomyBrainBrain regionBypassChemicalsDevelopmentDopamineDouble-Blind MethodElectronic Nicotine Delivery SystemsFlavoringFrequenciesFruitFunctional Magnetic Resonance ImagingHumanInhalationLaboratoriesLearningLightLinkLungMarketingMeasuresMediatingMolecular WeightNicotineNicotine DependenceNicotinic ReceptorsOral cavityOutcomePathway interactionsPersonsPhasePoliciesPopulation ResearchPreventionPrevention strategyProcessPsychological reinforcementPublic HealthRandomizedRandomized, Controlled TrialsReceptor Up-RegulationRegulationResearchRewardsRiskRoleSmokerStreamTaste PerceptionTranslatingTranslational ResearchTranslationsUnited StatesVentral Tegmental AreaYouthaddictionaddiction liabilityarmbiobehaviorcarcinogenicityelectronic liquidethyl acetatefood consumptionlipophilicityneurobehavioralneurobiological mechanismneurotransmissionnovelpre-clinicalpre-clinical researchreceptor upregulationsexstoichiometrytranslational study
项目摘要
Abstract
Of the more than 10 million people in the United States using electronic nicotine delivery systems (ENDS), the
vast majority are using e-liquids with non-tobacco flavors. Fruit flavors are by far the most popular among
established ENDS users of all ages, with an estimated 70% of youth and adults using fruit-flavored ENDS.
Most flavored e-liquids on the market use a combination of the same flavoring chemicals, which are approved
for food consumption, but not inhalation. While it is clear that flavors enhance the appeal of ENDS and
contribute to initiation, laboratory and population-based research has not established a clear link between
flavors and ENDS addiction potential, which is important for policy and prevention. Much of this research has
been conducted under the premise that flavors can enhance ENDS addiction potential through their appealing
taste. However, during inhalation, flavor chemicals in e-liquids move beyond the mouth to the lungs, where
they can enter the blood stream and pass through the blood-brain-barrier due to their low molecular weight and
lipophilicity. Rigorous preclinical research by our team demonstrates that some common flavor chemicals can
enhance ENDS reward and reinforcement and increase use frequency by directly altering nicotinic
acetylcholine receptor (nAChR) upregulation and stoichiometry. These nAChR alterations enhance dopamine
neurotransmission in the ventral tegmental area (VTA), a key brain region in addiction development. These
findings challenge our current conceptualization of how flavor can alter the addiction potential of ENDS by
pointing to a clear neurobehavioral mechanism of specific flavor chemicals. To date, these novel and important
preclinical findings have not been translated to humans. The proposed two-phase study will conduct a four-arm
double-blind randomized controlled trial of a neuro-active (hexyl acetate) vs. neuro-inactive (ethyl acetate)
ENDS green apple flavors with and without nicotine to determine the effects on biobehavioral markers of
addiction potential, including VTA flavor reactivity using functional magnetic resonance imaging and validated
laboratory tasks measuring the subjective reward value and relative reinforcement of flavored ENDS. The
specific aims of the R61 phase (n=50) are to: 1) Establish the cumulative vs. acute effects of ENDS flavor; and
2) Confirm that VTA flavor-reactivity is associated with ENDS subjective reward and reinforcement. If
milestones are met, the R33 phase (n=200) will include a fully-powered trial to: 1) Determine the independent
and interactive effects of flavor and nicotine on markers of addiction potential; 2) Determine if VTA reactivity
mediates the effects of ENDS flavor and nicotine on outcomes; and 3) Explore moderators of the flavor effects,
including sex and nicotine dependence. This study will be the first human translation of important and rigorous
preclinical research demonstrating a clear neurobehavioral mechanism for flavor’s ability to enhance ENDS
addiction potential. The results have the potential to fundamentally shift our understanding of and ability to
characterize the public health risks of flavored ENDS.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrea Hobkirk其他文献
Andrea Hobkirk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrea Hobkirk', 18)}}的其他基金
A human translation of research on the neurobehavioral reward and reinforcement of flavored electronic nicotine delivery systems (ENDS)
神经行为奖励和调味电子尼古丁输送系统 (ENDS) 强化研究的人类翻译
- 批准号:
10506990 - 财政年份:2022
- 资助金额:
$ 38.95万 - 项目类别:
Identifying circuit-level neuromarkers of smoking dependence that change in response to intervention
识别因干预而变化的吸烟依赖的回路水平神经标志物
- 批准号:
10434823 - 财政年份:2018
- 资助金额:
$ 38.95万 - 项目类别:
Identifying circuit-level neuromarkers of smoking dependence that change in response to intervention
识别因干预而变化的吸烟依赖的回路水平神经标志物
- 批准号:
10194436 - 财政年份:2018
- 资助金额:
$ 38.95万 - 项目类别:
NeuroAIDS research with disadvantaged drug users
针对弱势吸毒者的神经艾滋病研究
- 批准号:
8789503 - 财政年份:2014
- 资助金额:
$ 38.95万 - 项目类别:
相似海外基金
Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
- 批准号:
2885806 - 财政年份:2023
- 资助金额:
$ 38.95万 - 项目类别:
Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
- 批准号:
10772386 - 财政年份:2023
- 资助金额:
$ 38.95万 - 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
474619 - 财政年份:2022
- 资助金额:
$ 38.95万 - 项目类别:
Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
- 批准号:
485965 - 财政年份:2022
- 资助金额:
$ 38.95万 - 项目类别:
Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
466358 - 财政年份:2022
- 资助金额:
$ 38.95万 - 项目类别:
Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
- 批准号:
402040 - 财政年份:2019
- 资助金额:
$ 38.95万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 38.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
- 批准号:
377313 - 财政年份:2017
- 资助金额:
$ 38.95万 - 项目类别:
Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
- 批准号:
9315111 - 财政年份:2016
- 资助金额:
$ 38.95万 - 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
- 批准号:
8734273 - 财政年份:2013
- 资助金额:
$ 38.95万 - 项目类别:














{{item.name}}会员




